CEP: News Update

March
,
2017

Nucleic-acid-based molecules (DNA, RNA) have emerged in recent years as promising drugs for treating a range of genetic diseases, including cancer, diabetes, cystic fibrosis, hemophilia, and infectious, cardiovascular, inflammatory, and neurodegenerative diseases.

Thanks to a development at Michigan State Univ., the near future could include electronic tablets that can be easily stretched from mini-size to large, wallpaper that turns a room’s walls into a large display, and wearable health monitors.

Scientists at the Univ. of Utah have taken a page from nature’s playbook to produce ammonia at room temperature.

A new artificial skin made of the key ingredient in jam can detect changes in temperature by a mechanism similar to that used by pit vipers to detect their prey.

CRISPR is a promising gene-editing method that uses bacterial DNA to alter a cell’s genome. It has already been used to edit genes that were then injected into humans with aggressive lung cancer as part of a clinical trial in Chengdu, China.

A new polymer that acts as a template for DNA can sense particular genetic sequences that might foretell disease.

Copyright Permissions: 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.